世界の医薬品・CMO市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Pharmaceutical Products and CMO Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A12573 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、121ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、医薬品・CMOのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。医薬品・CMOの種類別市場規模（有効成分（API）、完成剤形（FDF）、医薬品包装）、用途別市場規模（スペシャリティ/ミッドサイズ、ジェネリック、ビッグファーマ、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・医薬品・CMOの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Catalent、DPx、Lonza、Piramal Healthcare、Aenova、Jubilant、Famar、Boehringer Ingelheim、Fareva Holding、AbbVie、Nipro Corp、Vetter、Sopharma、Mylan (DPT Laboratories)、Recipharm、NextPharma Technologies、Dishman、Aesica ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：有効成分（API）、完成剤形（FDF）、医薬品包装 ・用途別分析2016年-2026年：スペシャリティ/ミッドサイズ、ジェネリック、ビッグファーマ、その他 ・医薬品・CMOの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・医薬品・CMOのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・医薬品・CMOのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・医薬品・CMOの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・医薬品・CMOの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Pharmaceutical Products and CMO market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Pharmaceutical Products and CMO size is estimated to be USD 185990 million in 2026 from USD 152600 million in 2020, with a change XX% between 2020 and 2021. The global Pharmaceutical Products and CMO market size is expected to grow at a CAGR of 5.1% for the next five years.

Market segmentation
Pharmaceutical Products and CMO market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Active Pharmaceutical Ingredient (API)
Finished Dosage Form (FDF)
Pharmaceutical Packaging

Market segment by Application, can be divided into
Specialty/Midsize
Generics
Big Pharma
Others

Market segment by players, this report covers
Catalent
DPx
Lonza
Piramal Healthcare
Aenova
Jubilant
Famar
Boehringer Ingelheim
Fareva Holding
AbbVie
Nipro Corp
Vetter
Sopharma
Mylan (DPT Laboratories)
Recipharm
NextPharma Technologies
Dishman
Aesica

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Pharmaceutical Products and CMO
1.2 Classification of Pharmaceutical Products and CMO by Type
1.2.1 Overview: Global Pharmaceutical Products and CMO Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Pharmaceutical Products and CMO Revenue Market Share by Type in 2020
1.2.3 Active Pharmaceutical Ingredient (API)
1.2.4 Finished Dosage Form (FDF)
1.2.5 Pharmaceutical Packaging
1.3 Global Pharmaceutical Products and CMO Market by Application
1.3.1 Overview: Global Pharmaceutical Products and CMO Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Specialty/Midsize
1.3.3 Generics
1.3.4 Big Pharma
1.3.5 Others
1.4 Global Pharmaceutical Products and CMO Market Size & Forecast
1.5 Global Pharmaceutical Products and CMO Market Size and Forecast by Region
1.5.1 Global Pharmaceutical Products and CMO Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Pharmaceutical Products and CMO Market Size by Region, (2016-2021)
1.5.3 North America Pharmaceutical Products and CMO Market Size and Prospect (2016-2026)
1.5.4 Europe Pharmaceutical Products and CMO Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Pharmaceutical Products and CMO Market Size and Prospect (2016-2026)
1.5.6 South America Pharmaceutical Products and CMO Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Pharmaceutical Products and CMO Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Pharmaceutical Products and CMO Market Drivers
1.6.2 Pharmaceutical Products and CMO Market Restraints
1.6.3 Pharmaceutical Products and CMO Trends Analysis
2 Company Profiles
2.1 Catalent
2.1.1 Catalent Details
2.1.2 Catalent Major Business
2.1.3 Catalent Pharmaceutical Products and CMO Product and Solutions
2.1.4 Catalent Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Catalent Recent Developments and Future Plans
2.2 DPx
2.2.1 DPx Details
2.2.2 DPx Major Business
2.2.3 DPx Pharmaceutical Products and CMO Product and Solutions
2.2.4 DPx Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 DPx Recent Developments and Future Plans
2.3 Lonza
2.3.1 Lonza Details
2.3.2 Lonza Major Business
2.3.3 Lonza Pharmaceutical Products and CMO Product and Solutions
2.3.4 Lonza Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Lonza Recent Developments and Future Plans
2.4 Piramal Healthcare
2.4.1 Piramal Healthcare Details
2.4.2 Piramal Healthcare Major Business
2.4.3 Piramal Healthcare Pharmaceutical Products and CMO Product and Solutions
2.4.4 Piramal Healthcare Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Piramal Healthcare Recent Developments and Future Plans
2.5 Aenova
2.5.1 Aenova Details
2.5.2 Aenova Major Business
2.5.3 Aenova Pharmaceutical Products and CMO Product and Solutions
2.5.4 Aenova Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Aenova Recent Developments and Future Plans
2.6 Jubilant
2.6.1 Jubilant Details
2.6.2 Jubilant Major Business
2.6.3 Jubilant Pharmaceutical Products and CMO Product and Solutions
2.6.4 Jubilant Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Jubilant Recent Developments and Future Plans
2.7 Famar
2.7.1 Famar Details
2.7.2 Famar Major Business
2.7.3 Famar Pharmaceutical Products and CMO Product and Solutions
2.7.4 Famar Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Famar Recent Developments and Future Plans
2.8 Boehringer Ingelheim
2.8.1 Boehringer Ingelheim Details
2.8.2 Boehringer Ingelheim Major Business
2.8.3 Boehringer Ingelheim Pharmaceutical Products and CMO Product and Solutions
2.8.4 Boehringer Ingelheim Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Boehringer Ingelheim Recent Developments and Future Plans
2.9 Fareva Holding
2.9.1 Fareva Holding Details
2.9.2 Fareva Holding Major Business
2.9.3 Fareva Holding Pharmaceutical Products and CMO Product and Solutions
2.9.4 Fareva Holding Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Fareva Holding Recent Developments and Future Plans
2.10 AbbVie
2.10.1 AbbVie Details
2.10.2 AbbVie Major Business
2.10.3 AbbVie Pharmaceutical Products and CMO Product and Solutions
2.10.4 AbbVie Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 AbbVie Recent Developments and Future Plans
2.11 Nipro Corp
2.11.1 Nipro Corp Details
2.11.2 Nipro Corp Major Business
2.11.3 Nipro Corp Pharmaceutical Products and CMO Product and Solutions
2.11.4 Nipro Corp Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Nipro Corp Recent Developments and Future Plans
2.12 Vetter
2.12.1 Vetter Details
2.12.2 Vetter Major Business
2.12.3 Vetter Pharmaceutical Products and CMO Product and Solutions
2.12.4 Vetter Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Vetter Recent Developments and Future Plans
2.13 Sopharma
2.13.1 Sopharma Details
2.13.2 Sopharma Major Business
2.13.3 Sopharma Pharmaceutical Products and CMO Product and Solutions
2.13.4 Sopharma Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Sopharma Recent Developments and Future Plans
2.14 Mylan (DPT Laboratories)
2.14.1 Mylan (DPT Laboratories) Details
2.14.2 Mylan (DPT Laboratories) Major Business
2.14.3 Mylan (DPT Laboratories) Pharmaceutical Products and CMO Product and Solutions
2.14.4 Mylan (DPT Laboratories) Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Mylan (DPT Laboratories) Recent Developments and Future Plans
2.15 Recipharm
2.15.1 Recipharm Details
2.15.2 Recipharm Major Business
2.15.3 Recipharm Pharmaceutical Products and CMO Product and Solutions
2.15.4 Recipharm Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Recipharm Recent Developments and Future Plans
2.16 NextPharma Technologies
2.16.1 NextPharma Technologies Details
2.16.2 NextPharma Technologies Major Business
2.16.3 NextPharma Technologies Pharmaceutical Products and CMO Product and Solutions
2.16.4 NextPharma Technologies Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 NextPharma Technologies Recent Developments and Future Plans
2.17 Dishman
2.17.1 Dishman Details
2.17.2 Dishman Major Business
2.17.3 Dishman Pharmaceutical Products and CMO Product and Solutions
2.17.4 Dishman Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 Dishman Recent Developments and Future Plans
2.18 Aesica
2.18.1 Aesica Details
2.18.2 Aesica Major Business
2.18.3 Aesica Pharmaceutical Products and CMO Product and Solutions
2.18.4 Aesica Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2019-2021)
2.18.5 Aesica Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Pharmaceutical Products and CMO Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Pharmaceutical Products and CMO Players Market Share
3.2.2 Top 10 Pharmaceutical Products and CMO Players Market Share
3.2.3 Market Competition Trend
3.3 Pharmaceutical Products and CMO Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Pharmaceutical Products and CMO Revenue and Market Share by Type (2016-2021)
4.2 Global Pharmaceutical Products and CMO Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Pharmaceutical Products and CMO Revenue Market Share by Application (2016-2021)
5.2 Pharmaceutical Products and CMO Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Pharmaceutical Products and CMO Revenue by Type (2016-2026)
6.2 North America Pharmaceutical Products and CMO Revenue by Application (2016-2026)
6.3 North America Pharmaceutical Products and CMO Market Size by Country
6.3.1 North America Pharmaceutical Products and CMO Revenue by Country (2016-2026)
6.3.2 United States Pharmaceutical Products and CMO Market Size and Forecast (2016-2026)
6.3.3 Canada Pharmaceutical Products and CMO Market Size and Forecast (2016-2026)
6.3.4 Mexico Pharmaceutical Products and CMO Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Pharmaceutical Products and CMO Revenue by Type (2016-2026)
7.2 Europe Pharmaceutical Products and CMO Revenue by Application (2016-2026)
7.3 Europe Pharmaceutical Products and CMO Market Size by Country
7.3.1 Europe Pharmaceutical Products and CMO Revenue by Country (2016-2026)
7.3.2 Germany Pharmaceutical Products and CMO Market Size and Forecast (2016-2026)
7.3.3 France Pharmaceutical Products and CMO Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Pharmaceutical Products and CMO Market Size and Forecast (2016-2026)
7.3.5 Russia Pharmaceutical Products and CMO Market Size and Forecast (2016-2026)
7.3.6 Italy Pharmaceutical Products and CMO Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Pharmaceutical Products and CMO Revenue by Type (2016-2026)
8.2 Asia-Pacific Pharmaceutical Products and CMO Revenue by Application (2016-2026)
8.3 Asia-Pacific Pharmaceutical Products and CMO Market Size by Region
8.3.1 Asia-Pacific Pharmaceutical Products and CMO Revenue by Region (2016-2026)
8.3.2 China Pharmaceutical Products and CMO Market Size and Forecast (2016-2026)
8.3.3 Japan Pharmaceutical Products and CMO Market Size and Forecast (2016-2026)
8.3.4 South Korea Pharmaceutical Products and CMO Market Size and Forecast (2016-2026)
8.3.5 India Pharmaceutical Products and CMO Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Pharmaceutical Products and CMO Market Size and Forecast (2016-2026)
8.3.7 Australia Pharmaceutical Products and CMO Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Pharmaceutical Products and CMO Revenue by Type (2016-2026)
9.2 South America Pharmaceutical Products and CMO Revenue by Application (2016-2026)
9.3 South America Pharmaceutical Products and CMO Market Size by Country
9.3.1 South America Pharmaceutical Products and CMO Revenue by Country (2016-2026)
9.3.2 Brazil Pharmaceutical Products and CMO Market Size and Forecast (2016-2026)
9.3.3 Argentina Pharmaceutical Products and CMO Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Pharmaceutical Products and CMO Revenue by Type (2016-2026)
10.2 Middle East & Africa Pharmaceutical Products and CMO Revenue by Application (2016-2026)
10.3 Middle East & Africa Pharmaceutical Products and CMO Market Size by Country
10.3.1 Middle East & Africa Pharmaceutical Products and CMO Revenue by Country (2016-2026)
10.3.2 Turkey Pharmaceutical Products and CMO Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Pharmaceutical Products and CMO Market Size and Forecast (2016-2026)
10.3.4 UAE Pharmaceutical Products and CMO Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Pharmaceutical Products and CMO Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Pharmaceutical Products and CMO Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Pharmaceutical Products and CMO Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Pharmaceutical Products and CMO Revenue (USD Million) by Region (2016-2021)
Table 5. Global Pharmaceutical Products and CMO Revenue Market Share by Region (2021-2026)
Table 6. Catalent Corporate Information, Head Office, and Major Competitors
Table 7. Catalent Major Business
Table 8. Catalent Pharmaceutical Products and CMO Product and Solutions
Table 9. Catalent Pharmaceutical Products and CMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. DPx Corporate Information, Head Office, and Major Competitors
Table 11. DPx Major Business
Table 12. DPx Pharmaceutical Products and CMO Product and Solutions
Table 13. DPx Pharmaceutical Products and CMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Lonza Corporate Information, Head Office, and Major Competitors
Table 15. Lonza Major Business
Table 16. Lonza Pharmaceutical Products and CMO Product and Solutions
Table 17. Lonza Pharmaceutical Products and CMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Piramal Healthcare Corporate Information, Head Office, and Major Competitors
Table 19. Piramal Healthcare Major Business
Table 20. Piramal Healthcare Pharmaceutical Products and CMO Product and Solutions
Table 21. Piramal Healthcare Pharmaceutical Products and CMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Aenova Corporate Information, Head Office, and Major Competitors
Table 23. Aenova Major Business
Table 24. Aenova Pharmaceutical Products and CMO Product and Solutions
Table 25. Aenova Pharmaceutical Products and CMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Jubilant Corporate Information, Head Office, and Major Competitors
Table 27. Jubilant Major Business
Table 28. Jubilant Pharmaceutical Products and CMO Product and Solutions
Table 29. Jubilant Pharmaceutical Products and CMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Famar Corporate Information, Head Office, and Major Competitors
Table 31. Famar Major Business
Table 32. Famar Pharmaceutical Products and CMO Product and Solutions
Table 33. Famar Pharmaceutical Products and CMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Boehringer Ingelheim Corporate Information, Head Office, and Major Competitors
Table 35. Boehringer Ingelheim Major Business
Table 36. Boehringer Ingelheim Pharmaceutical Products and CMO Product and Solutions
Table 37. Boehringer Ingelheim Pharmaceutical Products and CMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Fareva Holding Corporate Information, Head Office, and Major Competitors
Table 39. Fareva Holding Major Business
Table 40. Fareva Holding Pharmaceutical Products and CMO Product and Solutions
Table 41. Fareva Holding Pharmaceutical Products and CMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. AbbVie Corporate Information, Head Office, and Major Competitors
Table 43. AbbVie Major Business
Table 44. AbbVie Pharmaceutical Products and CMO Product and Solutions
Table 45. AbbVie Pharmaceutical Products and CMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Nipro Corp Corporate Information, Head Office, and Major Competitors
Table 47. Nipro Corp Major Business
Table 48. Nipro Corp Pharmaceutical Products and CMO Product and Solutions
Table 49. Nipro Corp Pharmaceutical Products and CMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Vetter Corporate Information, Head Office, and Major Competitors
Table 51. Vetter Major Business
Table 52. Vetter Pharmaceutical Products and CMO Product and Solutions
Table 53. Vetter Pharmaceutical Products and CMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Sopharma Corporate Information, Head Office, and Major Competitors
Table 55. Sopharma Major Business
Table 56. Sopharma Pharmaceutical Products and CMO Product and Solutions
Table 57. Sopharma Pharmaceutical Products and CMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Mylan (DPT Laboratories) Corporate Information, Head Office, and Major Competitors
Table 59. Mylan (DPT Laboratories) Major Business
Table 60. Mylan (DPT Laboratories) Pharmaceutical Products and CMO Product and Solutions
Table 61. Mylan (DPT Laboratories) Pharmaceutical Products and CMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Recipharm Corporate Information, Head Office, and Major Competitors
Table 63. Recipharm Major Business
Table 64. Recipharm Pharmaceutical Products and CMO Product and Solutions
Table 65. Recipharm Pharmaceutical Products and CMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. NextPharma Technologies Corporate Information, Head Office, and Major Competitors
Table 67. NextPharma Technologies Major Business
Table 68. NextPharma Technologies Pharmaceutical Products and CMO Product and Solutions
Table 69. NextPharma Technologies Pharmaceutical Products and CMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. Dishman Corporate Information, Head Office, and Major Competitors
Table 71. Dishman Major Business
Table 72. Dishman Pharmaceutical Products and CMO Product and Solutions
Table 73. Dishman Pharmaceutical Products and CMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 74. Aesica Corporate Information, Head Office, and Major Competitors
Table 75. Aesica Major Business
Table 76. Aesica Pharmaceutical Products and CMO Product and Solutions
Table 77. Aesica Pharmaceutical Products and CMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 78. Global Pharmaceutical Products and CMO Revenue (USD Million) by Players (2019-2021)
Table 79. Global Pharmaceutical Products and CMO Revenue Share by Players (2019-2021)
Table 80. Breakdown of Pharmaceutical Products and CMO by Company Type (Tier 1, Tier 2 and Tier 3)
Table 81. Pharmaceutical Products and CMO Players Head Office, Products and Services Provided
Table 82. Pharmaceutical Products and CMO Mergers & Acquisitions in the Past Five Years
Table 83. Pharmaceutical Products and CMO New Entrants and Expansion Plans
Table 84. Global Pharmaceutical Products and CMO Revenue (USD Million) by Type (2016-2021)
Table 85. Global Pharmaceutical Products and CMO Revenue Share by Type (2016-2021)
Table 86. Global Pharmaceutical Products and CMO Revenue Forecast by Type (2021-2026)
Table 87. Global Pharmaceutical Products and CMO Revenue by Application (2016-2021)
Table 88. Global Pharmaceutical Products and CMO Revenue Forecast by Application (2021-2026)
Table 89. North America Pharmaceutical Products and CMO Revenue by Type (2016-2021) & (USD Million)
Table 90. North America Pharmaceutical Products and CMO Revenue by Type (2021-2026) & (USD Million)
Table 91. North America Pharmaceutical Products and CMO Revenue by Application (2016-2021) & (USD Million)
Table 92. North America Pharmaceutical Products and CMO Revenue by Application (2021-2026) & (USD Million)
Table 93. North America Pharmaceutical Products and CMO Revenue by Country (2016-2021) & (USD Million)
Table 94. North America Pharmaceutical Products and CMO Revenue by Country (2021-2026) & (USD Million)
Table 95. Europe Pharmaceutical Products and CMO Revenue by Type (2016-2021) & (USD Million)
Table 96. Europe Pharmaceutical Products and CMO Revenue by Type (2021-2026) & (USD Million)
Table 97. Europe Pharmaceutical Products and CMO Revenue by Application (2016-2021) & (USD Million)
Table 98. Europe Pharmaceutical Products and CMO Revenue by Application (2021-2026) & (USD Million)
Table 99. Europe Pharmaceutical Products and CMO Revenue by Country (2016-2021) & (USD Million)
Table 100. Europe Pharmaceutical Products and CMO Revenue by Country (2021-2026) & (USD Million)
Table 101. Asia-Pacific Pharmaceutical Products and CMO Revenue by Type (2016-2021) & (USD Million)
Table 102. Asia-Pacific Pharmaceutical Products and CMO Revenue by Type (2021-2026) & (USD Million)
Table 103. Asia-Pacific Pharmaceutical Products and CMO Revenue by Application (2016-2021) & (USD Million)
Table 104. Asia-Pacific Pharmaceutical Products and CMO Revenue by Application (2021-2026) & (USD Million)
Table 105. Asia-Pacific Pharmaceutical Products and CMO Revenue by Region (2016-2021) & (USD Million)
Table 106. Asia-Pacific Pharmaceutical Products and CMO Revenue by Region (2021-2026) & (USD Million)
Table 107. South America Pharmaceutical Products and CMO Revenue by Type (2016-2021) & (USD Million)
Table 108. South America Pharmaceutical Products and CMO Revenue by Type (2021-2026) & (USD Million)
Table 109. South America Pharmaceutical Products and CMO Revenue by Application (2016-2021) & (USD Million)
Table 110. South America Pharmaceutical Products and CMO Revenue by Application (2021-2026) & (USD Million)
Table 111. South America Pharmaceutical Products and CMO Revenue by Country (2016-2021) & (USD Million)
Table 112. South America Pharmaceutical Products and CMO Revenue by Country (2021-2026) & (USD Million)
Table 113. Middle East & Africa Pharmaceutical Products and CMO Revenue by Type (2016-2021) & (USD Million)
Table 114. Middle East & Africa Pharmaceutical Products and CMO Revenue by Type (2021-2026) & (USD Million)
Table 115. Middle East & Africa Pharmaceutical Products and CMO Revenue by Application (2016-2021) & (USD Million)
Table 116. Middle East & Africa Pharmaceutical Products and CMO Revenue by Application (2021-2026) & (USD Million)
Table 117. Middle East & Africa Pharmaceutical Products and CMO Revenue by Country (2016-2021) & (USD Million)
Table 118. Middle East & Africa Pharmaceutical Products and CMO Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Pharmaceutical Products and CMO Picture
Figure 2. Global Pharmaceutical Products and CMO Revenue Market Share by Type in 2020
Figure 3. Active Pharmaceutical Ingredient (API)
Figure 4. Finished Dosage Form (FDF)
Figure 5. Pharmaceutical Packaging
Figure 6. Pharmaceutical Products and CMO Revenue Market Share by Application in 2020
Figure 7. Specialty/Midsize Picture
Figure 8. Generics Picture
Figure 9. Big Pharma Picture
Figure 10. Others Picture
Figure 11. Global Pharmaceutical Products and CMO Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Pharmaceutical Products and CMO Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Pharmaceutical Products and CMO Revenue Market Share by Region (2016-2026)
Figure 14. Global Pharmaceutical Products and CMO Revenue Market Share by Region in 2020
Figure 15. North America Pharmaceutical Products and CMO Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Pharmaceutical Products and CMO Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Pharmaceutical Products and CMO Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Pharmaceutical Products and CMO Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Pharmaceutical Products and CMO Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Pharmaceutical Products and CMO Market Drivers
Figure 21. Pharmaceutical Products and CMO Market Restraints
Figure 22. Pharmaceutical Products and CMO Market Trends
Figure 23. Catalent Recent Developments and Future Plans
Figure 24. DPx Recent Developments and Future Plans
Figure 25. Lonza Recent Developments and Future Plans
Figure 26. Piramal Healthcare Recent Developments and Future Plans
Figure 27. Aenova Recent Developments and Future Plans
Figure 28. Jubilant Recent Developments and Future Plans
Figure 29. Famar Recent Developments and Future Plans
Figure 30. Boehringer Ingelheim Recent Developments and Future Plans
Figure 31. Fareva Holding Recent Developments and Future Plans
Figure 32. AbbVie Recent Developments and Future Plans
Figure 33. Nipro Corp Recent Developments and Future Plans
Figure 34. Vetter Recent Developments and Future Plans
Figure 35. Sopharma Recent Developments and Future Plans
Figure 36. Mylan (DPT Laboratories) Recent Developments and Future Plans
Figure 37. Recipharm Recent Developments and Future Plans
Figure 38. NextPharma Technologies Recent Developments and Future Plans
Figure 39. Dishman Recent Developments and Future Plans
Figure 40. Aesica Recent Developments and Future Plans
Figure 41. Global Pharmaceutical Products and CMO Revenue Share by Players in 2020
Figure 42. Pharmaceutical Products and CMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 43. Global Top 3 Players Pharmaceutical Products and CMO Revenue Market Share in 2020
Figure 44. Global Top 10 Players Pharmaceutical Products and CMO Revenue Market Share in 2020
Figure 45. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 46. Global Pharmaceutical Products and CMO Revenue Share by Type in 2020
Figure 47. Global Pharmaceutical Products and CMO Market Share Forecast by Type (2021-2026)
Figure 48. Global Pharmaceutical Products and CMO Revenue Share by Application in 2020
Figure 49. Global Pharmaceutical Products and CMO Market Share Forecast by Application (2021-2026)
Figure 50. North America Pharmaceutical Products and CMO Sales Market Share by Type (2016-2026)
Figure 51. North America Pharmaceutical Products and CMO Sales Market Share by Application (2016-2026)
Figure 52. North America Pharmaceutical Products and CMO Revenue Market Share by Country (2016-2026)
Figure 53. United States Pharmaceutical Products and CMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Canada Pharmaceutical Products and CMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Mexico Pharmaceutical Products and CMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Europe Pharmaceutical Products and CMO Sales Market Share by Type (2016-2026)
Figure 57. Europe Pharmaceutical Products and CMO Sales Market Share by Application (2016-2026)
Figure 58. Europe Pharmaceutical Products and CMO Revenue Market Share by Country (2016-2026)
Figure 59. Germany Pharmaceutical Products and CMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. France Pharmaceutical Products and CMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. United Kingdom Pharmaceutical Products and CMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Russia Pharmaceutical Products and CMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Italy Pharmaceutical Products and CMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Asia-Pacific Pharmaceutical Products and CMO Sales Market Share by Type (2016-2026)
Figure 65. Asia-Pacific Pharmaceutical Products and CMO Sales Market Share by Application (2016-2026)
Figure 66. Asia-Pacific Pharmaceutical Products and CMO Revenue Market Share by Region (2016-2026)
Figure 67. China Pharmaceutical Products and CMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Japan Pharmaceutical Products and CMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. South Korea Pharmaceutical Products and CMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. India Pharmaceutical Products and CMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Southeast Asia Pharmaceutical Products and CMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Australia Pharmaceutical Products and CMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. South America Pharmaceutical Products and CMO Sales Market Share by Type (2016-2026)
Figure 74. South America Pharmaceutical Products and CMO Sales Market Share by Application (2016-2026)
Figure 75. South America Pharmaceutical Products and CMO Revenue Market Share by Country (2016-2026)
Figure 76. Brazil Pharmaceutical Products and CMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Argentina Pharmaceutical Products and CMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Middle East and Africa Pharmaceutical Products and CMO Sales Market Share by Type (2016-2026)
Figure 79. Middle East and Africa Pharmaceutical Products and CMO Sales Market Share by Application (2016-2026)
Figure 80. Middle East and Africa Pharmaceutical Products and CMO Revenue Market Share by Country (2016-2026)
Figure 81. Turkey Pharmaceutical Products and CMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. Saudi Arabia Pharmaceutical Products and CMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 83. UAE Pharmaceutical Products and CMO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 84. Methodology
Figure 85. Research Process and Data Source

---